Treatment with DNase therapy or the use of PAD4-/- mice did not affect the progression of hepatic steatosis but altered the subsequent hepatic inflammation pattern, ultimately resulting in reduced tumor growth (36). The gene discussed is PADI4; the disease is neoplasm.